H1 Stock

h1.coHealthcare / Digital HealthFounded: 2019Funding to Date: $385.4MM

H1 is a health technology platform that aims to empower stakeholders at healthcare and life science companies to make smarter decisions using data. With a mission to connect doctors to the most relevant research information, the company offers tools like the AI-powered medical affairs and MSL platform, an investigative trial landscape, and provider data management for healthcare. H1 was founded in 2017 by Ariel Katz and Ian Sax and is headquartered in New York, NY.

Register To Buy and Sell Private Company Shares

For more details on private stock price information, financing and valuation for H1, register or login.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

H1 Stock Price

Forge Price 1
Price not yet available
Last Closed Trade 2
Close Date
xx/xx/xx
Last Closed Trade Price
$xx.xx
Last Funding Round (LFR)
Date
xx/xx/xx
Price per Share
$xx.xx

H1 Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
06/09/2022 Series C $120.96MM $xx.xx $773.23MM Altimeter Capital, Flex Capital, Goldman Sachs, Ivp, Leadedge Capital, Lux Capital, Menlo Ventures, Transformation Capital
Price per Share
$xx.xx
Shares Outstanding
5,049,470
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Altimeter Capital, Flex Capital, Goldman Sachs, Ivp, Leadedge Capital, Lux Capital, Menlo Ventures, Transformation Capital
12/17/2020 Series B-2 $169,623.38 $xx.xx $247.41MM Drx Capital, Ivp, Leadedge Capital, Lux Capital, Menlo Ventures, Transformation Capital, Y Combinator
Price per Share
$xx.xx
Shares Outstanding
53,672
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Drx Capital, Ivp, Leadedge Capital, Lux Capital, Menlo Ventures, Transformation Capital, Y Combinator
12/17/2020 Series B-1 $57.85MM $xx.xx $247.41MM Drx Capital, Ivp, Leadedge Capital, Lux Capital, Menlo Ventures, Transformation Capital, Y Combinator
Price per Share
$xx.xx
Shares Outstanding
6,412,544
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Drx Capital, Ivp, Leadedge Capital, Lux Capital, Menlo Ventures, Transformation Capital, Y Combinator
04/22/2020 Series A-3 $150,007.62 $xx.xx $35.49MM Clearpoint Investment Partners, Drx Capital, Liquid 2 Ventures, Menlo Ventures, Underscore Vc, Y Combinator
Price per Share
$xx.xx
Shares Outstanding
955,280
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Clearpoint Investment Partners, Drx Capital, Liquid 2 Ventures, Menlo Ventures, Underscore Vc, Y Combinator
04/22/2020 Series A-2 $585,004.00 $xx.xx $35.49MM Clearpoint Investment Partners, Drx Capital, Liquid 2 Ventures, Menlo Ventures, Underscore Vc, Y Combinator
Price per Share
$xx.xx
Shares Outstanding
309,503
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Clearpoint Investment Partners, Drx Capital, Liquid 2 Ventures, Menlo Ventures, Underscore Vc, Y Combinator
04/22/2020 Series A-1 $12.98MM $xx.xx $35.49MM Clearpoint Investment Partners, Drx Capital, Liquid 2 Ventures, Menlo Ventures, Underscore Vc, Y Combinator
Price per Share
$xx.xx
Shares Outstanding
5,493,762
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Clearpoint Investment Partners, Drx Capital, Liquid 2 Ventures, Menlo Ventures, Underscore Vc, Y Combinator

H1 Investors Also Invested in These Private Companies

H1 stock FAQs

plusminus

Can you buy H1 stock?

As H1 is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private companies like H1, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.
plusminus

How to buy H1 stock?

To invest in a private company like H1 through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell H1 stock?

Yes, you may sell the H1 stock you currently own. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company’s interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell H1 stock?

If you hold private company shares of H1 – whether as an employee or an early investor – Forge can help you sell them.

  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your H1 on our platform.
  3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.
plusminus

Is H1 a public company?

No, H1 is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is H1’s stock price?

H1 is a privately held company and therefore does not have a public stock price. However, you may access H1 private market stock price with Forge Data.
plusminus

What is H1’s stock ticker symbol?

H1 does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

H1 News and Media Highlights

Healthtech company H1 adds new AI tech to clinical trial arm

Healthcare platform company H1 is diving deeper into the power of artificial intelligence, adding GenosAI to its clinical trials arm, Trial Landscape. The new tech, unveiled Thursday, is described as incorporating a “ChatGPT-like” experience into Trial Landscape, which clients use to help establish new clinical trials. Users will be able to pose questions on the platform that GenosAI can respond to with the aid of natural language processing, such as inquiring about the best-performing trial sites or suitable locations for a particular disease area.

Health tech startup H1 banks $100M to expand its digital doctor network for pharma, medical device companies

Startup H1 developed a massive digital professional database and data analytics platform that connects healthcare professionals and life science companies. It basically serves as a LinkedIn for the pharmaceutical and biotech industries. The company just picked up $100 million in a series C round to expand its data and network as well as its product development and hiring, with a goal to make H1 the core global healthcare network for every medical professional and organization in the world, according to the company.

H1 Launches H1 Explorer, Most Comprehensive Platform of Healthcare Professionals On the Internet Where HCPs Can Now Claim and Update their Profiles

HCPs can now update profiles on largest global healthcare platform to own their narrative and get in front of key stakeholders in the medical, life...

Healthcare Data Startup H1 Acquires Carevoyance, Accelerating Entry into the Fast-Growing Medical Device Market

H1, which provides the largest global healthcare platform that connects healthcare professionals, announced today that it has acquired Portland, Oregon based Carevoyance, which offers ​​the best targeting, sales enablement, and physician segmentation platform to medical device sellers. he acquisition enables H1 to expand its presence in the medical device market, and allows Carevoyance - which will continue to operate independently, as a subsidiary of H1 - to include H1’s proprietary data in its product offering to provide more value to clients.
Browse Insights
Updated on: Dec 23, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge.  Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.